ENDRA LIFE SCIENCES INC.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 |
|---|---|---|---|
| Revenue | $6.2K | $351.6K | $515.6K |
| Cost of Revenue | $0 | $172.8K | — |
| Gross Profit | $6.2K | $178.8K | $279.7K |
| Gross Margin | 100.0% | 50.9% | 54.3% |
| Operating Expenses | |||
| Research & Development | $4.7M | $1.9M | $495.4K |
| SG&A Expense | $3.8M | $2.8M | $1.5M |
| Operating Income | $-9.0M | $-4.6M | $-1.8M |
| Operating Margin | -146,080.5% | -1,315.6% | -347.5% |
| Interest Expense | $0 | $42.6K | $72.0K |
| Pretax Income | $-9.8M | $-5.4M | $-2.8M |
| Income Tax Expense | $0 | $0 | $0 |
| Net Income | $-9.8M | $-5.4M | $-2.8M |
| Net Margin | -158,669.6% | -1,529.2% | -538.3% |
| EPS (Basic) | $-0.01 | $-0.01 | $-0.02 |
| EPS (Diluted) | $-0.01 | $-0.01 | $-0.02 |
| Shares Outstanding (Basic) | 1.66B | 878.8M | 162.0M |
| Shares Outstanding (Diluted) | 1.66B | 878.8M | 162.0M |
| Dividends Per Share | — | — | — |